PT96401A - Processo de preparacao de particulas em po em particular a base de mianserina - Google Patents

Processo de preparacao de particulas em po em particular a base de mianserina

Info

Publication number
PT96401A
PT96401A PT96401A PT9640190A PT96401A PT 96401 A PT96401 A PT 96401A PT 96401 A PT96401 A PT 96401A PT 9640190 A PT9640190 A PT 9640190A PT 96401 A PT96401 A PT 96401A
Authority
PT
Portugal
Prior art keywords
preparation
mianserina
particles
basis
psychotropic
Prior art date
Application number
PT96401A
Other languages
English (en)
Other versions
PT96401B (pt
Inventor
Gerrit Bernardus Maria Beuving
Henrik De Nijs
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT96401A publication Critical patent/PT96401A/pt
Publication of PT96401B publication Critical patent/PT96401B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT96401A 1989-12-30 1990-12-28 Processo de preparacao de particulas em po em particular a base de mianserina PT96401B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8903199 1989-12-30

Publications (2)

Publication Number Publication Date
PT96401A true PT96401A (pt) 1991-10-15
PT96401B PT96401B (pt) 1998-06-30

Family

ID=19855853

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96401A PT96401B (pt) 1989-12-30 1990-12-28 Processo de preparacao de particulas em po em particular a base de mianserina

Country Status (14)

Country Link
US (1) US5238688A (pt)
EP (1) EP0436252B1 (pt)
JP (1) JP3051459B2 (pt)
KR (1) KR0156735B1 (pt)
AT (1) ATE93136T1 (pt)
AU (1) AU634614B2 (pt)
CA (1) CA2033418C (pt)
DE (1) DE69002822T2 (pt)
DK (1) DK0436252T3 (pt)
ES (1) ES2060001T3 (pt)
IE (1) IE63986B1 (pt)
NZ (1) NZ236626A (pt)
PT (1) PT96401B (pt)
ZA (1) ZA9010452B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328688A (en) * 1990-09-10 1994-07-12 Arch Development Corporation Recombinant herpes simplex viruses vaccines and methods
DE69913116T2 (de) * 1998-04-02 2004-06-03 Akzo Nobel N.V. Orale flüssige lösung enthaltend das antidepressivum mirtazapine
US6492320B2 (en) * 1999-09-24 2002-12-10 Rohm And Hass Company Multifunctional, granulated pellet aid and process
TWI256309B (en) * 1999-10-13 2006-06-11 Akzo Nobel Nv New formulation of mirtazapine
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
JPS5665825A (en) * 1979-10-31 1981-06-03 Mochida Pharmaceut Co Ltd Remedy for peptic ulcer
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
US4870060A (en) * 1985-03-15 1989-09-26 Janssen Pharmaceutica Derivatives of γ-cylodextrin
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2038669T3 (es) * 1986-09-18 1993-08-01 London School Of Pharmacy Innovations Ltd Formulacion farmaceutica.
DE3856555T2 (de) * 1987-10-16 2004-04-29 Elan Corp. Plc Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
EP0319061A1 (en) * 1987-11-28 1989-06-07 Akzo N.V. Medicament with antiemetic action

Also Published As

Publication number Publication date
DE69002822T2 (de) 1993-12-23
EP0436252A1 (en) 1991-07-10
JPH04210638A (ja) 1992-07-31
ATE93136T1 (de) 1993-09-15
JP3051459B2 (ja) 2000-06-12
IE63986B1 (en) 1995-06-28
KR910011266A (ko) 1991-08-07
ZA9010452B (en) 1991-10-30
PT96401B (pt) 1998-06-30
AU6839890A (en) 1991-07-04
ES2060001T3 (es) 1994-11-16
AU634614B2 (en) 1993-02-25
CA2033418A1 (en) 1991-07-01
KR0156735B1 (ko) 1998-11-16
US5238688A (en) 1993-08-24
DK0436252T3 (da) 1993-12-27
NZ236626A (en) 1992-10-28
DE69002822D1 (de) 1993-09-23
CA2033418C (en) 2002-05-14
EP0436252B1 (en) 1993-08-18
IE904531A1 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
HUT63356A (en) Method for producing granular, absorbent polymer preparations containing cross-binding aggregates being among particles
NZ227869A (en) Ultrasonic contrast agents containing amylose microparticles
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
GR850023B (pt)
GR900300017T1 (en) Process for the agglomeration of water-swellable polymers by sinter granulation
PT96401A (pt) Processo de preparacao de particulas em po em particular a base de mianserina
BR9007399A (pt) Composicao,processo para sua preparacao,processo para preparacao de particulas fibrosas e particulas fibrosas
DE69109021D1 (de) Augentropfenarzneimittel.
ATE230618T1 (de) Fibrin-gewebekleber-formulierung und verfahren zu dessen herstellung
ATE138590T1 (de) Pyrogensorbentmittel
NO178734C (no) Fremgangsmåte for fremstilling av en ny arginin-deiminase
BR9905826A (pt) Sorbitol pulverulento e seu processo de preparação
BR9714343A (pt) Partìcula detergente
GR3021366T3 (en) Blends of cellulose and synthetic polymers, manufacture and uses thereof
GB2232988B (en) "glass fibres, process for production thereof and use thereof"
HUT53773A (en) Antidotums containing substituted 1,8-naphtiridine derivatives as aktive components and process for producing the active components
EP0254239A3 (en) Optically pure 1,3-dioxenones, methods for preparing same and use thereof
FI892257A (fi) Anordning foer infoerande, pressning och uttagning av ett skiktpaket i resp. ur en varmpress.
ATE308318T1 (de) Trägerstoff zur verzögerten freisetzung
BR9103782A (pt) Comosicoes de borracha vulcanizaveis com enxofre contendo n,n'-(m-tenileno)bismaleimida
DE50014675D1 (de) Granulatförmige Organosilan-Präparation, Verfahren zu ihrer Herstellung und ihrer Verwendung
GB8910114D0 (en) Process for the preparation of gelatine/cyclodextrin polymers
IT1226147B (it) Processo per la preparazione di perfluoro (2 bromoetilviniletere).
AU8803891A (en) Thrombin-binding substance and process for preparing the same
DE69207839D1 (de) Anordnung zur Herstellung von Trägerteilchen

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910531

FG3A Patent granted, date of granting

Effective date: 19980327

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070927